DMK PHARMACEUTICALS CORPORATION Share-based Payment Arrangement, Expense
DMK PHARMACEUTICALS CORPORATION reported Share-based Payment Arrangement, Expense of -$44.69 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-11-14
- DMK PHARMACEUTICALS CORPORATION share-based payment arrangement, expense for the quarter ending 2023-09-30 was -$44.69K, a 160.00% decline year-over-year.
- DMK PHARMACEUTICALS CORPORATION share-based payment arrangement, expense for the quarter ending 2023-06-30 was $52.20K.
- DMK PHARMACEUTICALS CORPORATION share-based payment arrangement, expense for the quarter ending 2023-03-31 was $69.29K, a 81.38% decline year-over-year.
- DMK PHARMACEUTICALS CORPORATION share-based payment arrangement, expense for the quarter ending 2022-12-31 was -$325.96K.
- DMK PHARMACEUTICALS CORPORATION share-based payment arrangement, expense for fiscal 2022 was -$340.27K, a 116.87% decline from fiscal 2021.
- DMK PHARMACEUTICALS CORPORATION share-based payment arrangement, expense for fiscal 2021 was $2.02M.
- DMK PHARMACEUTICALS CORPORATION share-based payment arrangement, expense for fiscal 2013 was $36.79K, a 89.92% decline from fiscal 2012.
- DMK PHARMACEUTICALS CORPORATION share-based payment arrangement, expense for fiscal 2012 was $364.88K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$44.69K 10-Q · filed 2023-11-14 | $7.50K derived: sum of 2 quarters · filed 2023-11-14 | $76.80K 10-Q · filed 2023-11-14 | -$249.16K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $52.20K 10-Q · filed 2023-08-21 | $121.49K 10-Q · filed 2023-08-21 | -$204.47K derived: sum of 3 quarters · filed 2023-08-21 | -$129.98K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | $69.29K 10-Q · filed 2023-05-15 | -$256.67K derived: sum of 2 quarters · filed 2023-05-15 | -$182.18K derived: sum of 3 quarters · filed 2023-11-14 | -$643.09K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | -$325.96K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$251.47K derived: sum of 2 quarters · filed 2023-11-14 | -$712.39K derived: sum of 3 quarters · filed 2023-11-14 | -$340.27K 10-K · filed 2023-03-16 |
| 2022-09-30 | $74.49K 10-Q · filed 2023-11-14 | -$386.43K derived: sum of 2 quarters · filed 2023-11-14 | -$14.31K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$460.92K 10-Q · filed 2023-08-21 | -$88.80K 10-Q · filed 2023-08-21 | ||
| 2022-03-31 | $372.12K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $2.02M 10-K · filed 2023-03-16 | |||
| 2013-12-31 | $11.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | $29.58K derived: sum of 2 quarters · filed 2014-02-14 | $47.33K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $17.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-13 | $35.50K 10-Q · filed 2013-11-13 | ||
| 2013-06-30 | $17.75K 10-Q · filed 2013-08-19 | |||
| 2013-03-31 | $36.79K 10-K · filed 2013-07-03 | |||
| 2012-03-31 | $364.88K 10-K · filed 2013-07-03 |